Hazardous crossing: Immunosuppression and nosocomial infections in solid organ transplant recipients

Surgical Infections

Volumn 2, Issue 2, 2001, Pages 103-110

  Dun, D L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZITHROMYCIN; CASPOFUNGIN; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOSERINE; DAPSONE; ERYTHROMYCIN; ETHAMBUTOL; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; LEVOFLOXACIN; PENTAMIDINE; RIFAMPICIN; SULFAFURAZOLE; TRIMETHOPRIM; VALACICLOVIR;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; LETHALITY; MYCOSIS; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECIPIENT; VIRULENCE; VIRUS INFECTION;

EID: 0034827445     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/109629601750469429     Document Type: Article

References (44)

1. Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report
2. Solid organ transplantation
3. Analysis of infectious complications occurring after solid-organ transplantation
4. Urinary tract infections following renal transplantation
5. Surgical wound infection in renal transplantation: Outcome data in 102 consecutive patients without perioperative systemic antibiotic coverage
6. Prevalence of urinary tract infection during outpatient follow-up after renal transplantation
7. Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients
8. Characterization and impact of wound infection after pancreas transplantation
9. Post-transplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients
10. Outcome analysis of 71 clinical intestinal transplantations
11. Surgical complications of liver transplantation
12. Management of infectious complications following liver transplantation
13. Infections in heart-lung transplant recipients
14. Early bacterial infections in lung transplant recipients
15. Strategies for prevention of infection after cardiac transplantation
16. Bacterial pneumonia in solid organ transplantation
17. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients
18. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis
19. Endotoxin antagonism
20. Listeriosis in renal transplant recipients: Report of an outbreak and review of 102 cases
21. Listeria monocytogenes hepatitis in a liver transplant recipient: A case report and review of the literature
22. Nocardiosis in renal transplant patients
23. Nocardial brain abscess in a renal transplant recipient successfully treated with triple antimicrobials
24. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management
25. Legionella: A major opportunistic pathogen in transplant recipients
26. Clinical aspects of fungal infection in organ transplant recipients
27. Opportunistic fungal and bacterial infection in the renal transplant recipient
28. Aspergillus and lung transplant recipients: A mycologic and molecular epidemiologic study
29. Cutaneous Mucor infection treated with wide excision in two children who underwent marrow transplantation
30. Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients
31. The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus
32. Diagnosis and treatment of opportunistic infections in immunocompromised surgical patients
33. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?
34. Susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis
35. Diagnosis and treatment of transplant-related lymphoma
36. Posttransplant lymphoproliferative disorders
37. Fulminant posttransplant lymphoproliferative disorder presenting as multisystem organ failure
38. Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients
39. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir
40. Cytomegalovirus infection and disease after solid organ transplantation: Epidemiology, prevention and therapy
41. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts
42. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation
43. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation
44. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation